Bilateral Papilledema in Idiopathic Intracranial Hypertension: A Case Report
Main Article Content
Keywords
Idiopathic Intracranial Hypertension, Obesity, Headaches, Acetazolamide
Abstract
Introduction: Idiopathic intracranial hypertension (IIH) or known as pseudo tumor cerebri is a challenging condition with raised intracranial pressure (ICP) in the absence of an identifiable cause. IIH occurs predominantly in women, and it has a striking association with obesity. The majority of patients presenting with IIH have symptoms that include a headache and visual disturbances. IIH presents challenges in management. This case report aims to discuss the clinical signs and management of idiopathic intracranial hypertension.
Case Report: A female 21 years old presented with visual field disturbances complaints since one week before admitted to the Hospital. Her symptom progressively worsened over time with headaches. Blood pressure was 150/80 mmHg, body weight was 110 kg, height was 167 cm, and body mass index was 40 kg/m2. Visual acuity in both eyes was 6/6. The intraocular pressure was 17 mmHg on the right eye and 18 mmHg on the left eye. There was a constriction of vision's peripheral field and enlarged blind spot with Humphrey 24-2 visual field test. Fundus examination with optical coherence tomography of retinal nerve fiber layer revealed bilateral papilledema. The patient was diagnosed with papilledema et causa Idiopathic Intracranial Hypertension in both eyes. The patient was treated with acetazolamide and combination therapy with the neurology department.
Conclusion: IIH is a challenging disease with a collaborative department. Early and aggressive management is required to prevent irreversible visual impairment.
References
2. Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016; 15:78–91. DOI: 10.1016/S1474-4422(15)00298-7
3. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013; 81:1159–65. DOI: 10.1212/WNL.0b013e3182a55f17
4. Donnet A, Metellus P, Levrier O, Mekkaoui C, Fuentes S, Dufour H, et al: Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008; 70:641–647. DOI: 10.1212/01.wnl.0000299894.30700.d2
5. Kilgore KP, Lee MS, Leavitt JA, et al. Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology. 2017; 124:697–700. DOI: 10.1016/j.ophtha.2017.01.006
6. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013; 33:629–808. DOI: 10.1177/0333102413485658
7. Yri HM, Jensen RH. Idiopathic intracranial hypertension: clinical nosography and field-testing of the ICHD diagnostic criteria. A case-control study. Cephalalgia. 2015; 35:553–62. DOI: 10.1177/0333102414550109
8. Nisha G, Smruti KP, Amanda O, Aria N, Peyman S, Aaron WG, Joseph C, Mario Z, and Charles JP. Understanding the complex pathophysiology of idiopathic intracranial hypertension and the evolving role of venous sinus stenting: a comprehensive review of the literature. Neurosurg Focus. 2018; 45 (1):E10. DOI: 10.3171/2018.4.FOCUS18100
9. Carta, A., Bertuzzi, F., Cologno, D., Giorgi, C., Montanari, E. and Tedesco, S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur J Ophthalmol. 2014; 14: 48–54. DOI: 10.1177/112067210401400108
10. Mollan, S., Markey, K., Benzimra, J., Jacks, A., Matthews, T., Burdon, M. et al. A practical approach to diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol. 2014; 14: 380–390. DOI: 10.1136/practneurol-2014-000821
11. Craig, J., Mulholland, D. and Gibson, J. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991-1995). Ulster Med J. 2001; 70: 31–35. PMCID: PMC2449216
12. Mulla, Y., Markey, K., Woolley, R., Patel, S., Mollan, S. and Sinclair, A. Headache determines
quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015; 16: 521. DOI: 10.1186/s10194-015-0521-9
13. De Simone, R., Ranieri, A., Montella, S., Cappabianca, P., Quarantelli, M., Esposito, F. et al. Intracranial pressure in unresponsive chronic migraine. J Neurol. 2014; 261: 1365–1373. DOI: 10.1007/s00415-014-7355-2
14. Zur, D., Naftaliev, E. and Kesler, A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015; 35: 26–30. DOI:10.1097/WNO.0000000000000199
15. Skau, M., Milea, D., Sander, B., Wegener, M. and Jensen, R. OCT for optic disc evaluation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2011; 249: 723–730. DOI: 10.1007/s00417-010-1527-2
16. Rebolledo, G. and Munoz-Negrete, F. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009; 50: 5197–5200. DOI: https://doi.org/10.1167/iovs.08-2528
17. Karam EZ,Hedges TR. Optical coherence tomography of the retinal nerve fiber layer in mild papilloedema and pseudopapilloedema. Br J Ophthalmol. 2005; 89:294–8. DOI: 10.1136/bjo.2004.049486
18. Bebolleda G, Munoz-Negrete FJ. Follow up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthalmol Vis Sci. 2009; 50:5197–200. DOI: https://doi.org/10.1167/iovs.08-2528
19. Ahuja S, Anand D, Dutta TK, et al. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography—a case-control study. Clin Neurol Neurosurg. 2015; 136:95–9. DOI: 10.1016/j.clineuro.2015.05.002
20. Optical Coherence Tomography Sub-study Committee, NORDIC Idiopathic Intracranial Hypertension Study Group. Papilledema outcomes from the Optical Coherence Tomography Sub-study of the Idiopathic intracranial hypertension treatment trial. Ophthalmology. 2015; 122:1939–45. DOI: 10.1016/j.ophtha.2015.06.003
21. Friedman, D., Liu, G. and Digre, K. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013; 81: 1159–1165. DOI: 10.1212/WNL.0b013e3182a55f17
22. Sinclair, A., Burdon, M., Nightingale, P., Ball, A., Good, P., Matthews, T. et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010; 341: c2701. DOI: https://doi.org/10.1136/bmj.c2701
23. Fridley, J., Foroozan, R., Sherman, V., Brandt, M. and Yoshor, D. Bariatric surgery for the treatment of idiopathic intracranial hypertension. J Neurosurg. 200; 114: 34–39. DOI: 10.3171/2009.12.JNS09953
24. Ball, A., Howman, A., Wheatley, K., Burdon, M., Matthews, T., Jacks, A. et al. A randomized controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 200; 258: 874–881. DOI: 10.1007/s00415-010-5861-4
25. Best, J., Silvestri, G., Burton, B., Foot, B. and Acheson, J. The Incidence of Blindness Due to
Idiopathic Intracranial Hypertension in the UK. Open Ophthalmol J. 2013; 7: 26–29. DOI: 10.2174/1874364101307010026